Sarepta Therapeutics, Inc. (SRPT)
Healthcare • Biotechnology
StockNasdaqGSUnited StatesUS8036071004
16.03 USD
+0.12% today Updated 13 Nov 2026 15:31
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Sarepta Therapeutics, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 15:31. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
24 Feb 2027
in 103 days · 16:00 · estimate -0.17
Last results
0.13 vs 0.36 estimated
05 Nov 2026 · Miss -63.6%
Beat the estimate
7 of 12
5 missed · 0 in line
Average surprise
-19.1%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 24 Feb 2027 16:00 | -0.17 | — | — | Upcoming |
| 05 Nov 2026 16:00 | 0.36 | 0.13 | -63.6% | Miss |
| 05 Aug 2026 16:00 | 0.49 | 0.64 | +31.7% | Beat |
| 06 May 2026 16:00 | 1.05 | 3.16 | +202.1% | Beat |
| 25 Feb 2026 16:00 | -0.77 | -3.58 | -365.3% | Miss |
| 03 Nov 2025 16:00 | -0.37 | -0.13 | +65.0% | Beat |
| 06 Aug 2025 16:00 | 1.16 | 2.02 | +73.9% | Beat |
| 06 May 2025 16:00 | -0.65 | -3.42 | -426.6% | Miss |
| 26 Feb 2025 16:00 | 2.06 | 1.90 | -7.8% | Miss |
| 06 Nov 2024 16:00 | 0.37 | 0.62 | +67.0% | Beat |
| 07 Aug 2024 16:00 | 0.47 | 0.44 | -5.5% | Miss |
| 01 May 2024 16:00 | 0.41 | 0.73 | +77.4% | Beat |
| 28 Feb 2024 16:00 | 0.37 | 0.82 | +122.7% | Beat |
| 01 Nov 2023 16:00 | -0.49 | 0.37 | +175.7% | Beat |
| 02 Aug 2023 16:00 | -1.00 | -0.85 | +15.4% | Beat |
| 02 May 2023 16:00 | -0.83 | -0.97 | -16.2% | Miss |
| 28 Feb 2023 16:00 | -0.93 | -0.53 | +42.9% | Beat |
| 02 Nov 2022 16:00 | -0.74 | -0.80 | -8.3% | Miss |
| 02 Aug 2022 16:00 | -0.60 | -1.18 | -96.1% | Miss |
| 04 May 2022 16:00 | -1.03 | -0.56 | +45.6% | Beat |
| 01 Mar 2022 16:00 | -1.14 | -0.77 | +32.2% | Beat |
| 03 Nov 2021 16:00 | -1.52 | -0.19 | +87.5% | Beat |
| 04 Aug 2021 16:00 | -1.29 | -1.52 | -18.2% | Miss |
| 05 May 2021 16:00 | -1.57 | -1.54 | +1.6% | Beat |
| 01 Mar 2021 16:00 | -1.46 | -1.84 | -25.9% | Miss |
| 05 Nov 2020 16:00 | -1.40 | -1.42 | -1.4% | Miss |
| 05 Aug 2020 16:00 | -1.31 | -1.51 | -15.1% | Miss |
| 06 May 2020 17:00 | 1.93 | -1.04 | -153.9% | Miss |
| 26 Feb 2020 16:00 | -1.27 | -1.57 | -23.6% | Miss |
| 07 Nov 2019 16:00 | -0.92 | -1.14 | -24.0% | Miss |
| 07 Aug 2019 16:00 | -0.77 | -0.83 | -8.2% | Miss |
| 08 May 2019 16:00 | -0.81 | -0.75 | +6.9% | Beat |
| 27 Feb 2019 16:00 | -0.73 | -0.85 | -15.8% | Miss |
| 24 Oct 2018 16:00 | -0.49 | -0.56 | -14.9% | Miss |
| 08 Aug 2018 16:00 | -0.33 | -0.43 | -32.0% | Miss |
| 03 May 2018 16:00 | -0.24 | -0.28 | -15.1% | Miss |
| 01 Mar 2018 16:00 | -0.17 | -0.28 | -62.8% | Miss |
| 25 Oct 2017 16:00 | -0.77 | -0.33 | +57.5% | Beat |
| 19 Jul 2017 16:00 | -0.78 | -0.65 | +17.2% | Beat |
| 27 Apr 2017 16:00 | -0.94 | -0.60 | +36.5% | Beat |
| 28 Feb 2017 16:00 | -1.09 | -0.71 | +34.7% | Beat |
| 27 Oct 2016 07:00 | -1.28 | -0.95 | +25.9% | Beat |
| 19 Jul 2016 16:00 | -1.21 | -1.19 | +1.5% | Beat |
| 05 May 2016 07:00 | -1.14 | -1.15 | -0.7% | In line |
| 25 Feb 2016 16:00 | -1.17 | -1.30 | -10.8% | Miss |
| 05 Nov 2015 07:00 | -1.10 | -1.11 | -0.5% | In line |
| 06 Aug 2015 07:00 | -1.23 | -0.87 | +29.5% | Beat |
| 07 May 2015 07:00 | -0.94 | -1.49 | -58.4% | Miss |
| 26 Feb 2015 07:00 | -0.74 | -1.08 | -44.7% | Miss |
| 06 Nov 2014 07:00 | -0.94 | -0.70 | +25.5% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 2.2B | +15.6% | -713.4M | -32.5% | -7.13 | -404.7% | -315.3M |
| 2024 | 1.9B | +53.0% | 235.2M | 12.4% | 2.34 | +140.3% | -352.7M |
| 2023 | 1.2B | +33.3% | -536M | -43.1% | -5.80 | +27.8% | -588.3M |
| 2022 | 933M | — | -703.5M | -75.4% | -8.03 | — | -357.6M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 18.65 | 19.28 | 15.70 | 15.99 | -14.12% | 18,760,722 | |
| Oct 2026 | 18.14 | 19.70 | 16.37 | 18.62 | +2.20% | 60,979,500 | |
| Sep 2026 | 20.88 | 23.62 | 17.64 | 18.22 | -13.36% | 61,808,800 | |
| Aug 2026 | 15.09 | 22.59 | 14.75 | 21.03 | +41.52% | 62,775,100 | |
| Jul 2026 | 18.23 | 20.88 | 14.84 | 14.86 | -17.31% | 69,584,100 | |
| Jun 2026 | 17.59 | 18.22 | 14.68 | 17.97 | +0.56% | 81,243,500 | |
| May 2026 | 20.93 | 23.49 | 16.42 | 17.87 | -14.42% | 62,729,700 | |
| Apr 2026 | 21.92 | 23.84 | 18.38 | 20.88 | -4.04% | 51,494,000 | |
| Mar 2026 | 16.28 | 23.85 | 15.53 | 21.76 | +29.83% | 75,848,600 | |
| Feb 2026 | 20.01 | 21.36 | 16.41 | 16.76 | -17.60% | 45,141,600 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Sarepta Therapeutics, Inc. 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 10 Nov 2026 18:35
- DraftKings downgraded, Sarepta upgraded: Wall Street's top analyst calls (opens in a new tab) The Fly · 10 Nov 2026 14:46
- Sarepta Therapeutics Sees Transformational 2027 as Rare Disease Programs Advance (opens in a new tab) MarketBeat · 09 Nov 2026 22:12
- Sarepta Therapeutics, Inc. (SRPT) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 07 Nov 2026 22:14
- Learn Why The Bull Case For Sarepta Therapeutics Stock Could Change Following Raised Revenue Guidance (opens in a new tab) Simply Wall St. · 07 Nov 2026 11:14
- Sarepta (SRPT) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 06 Nov 2026 16:14
- RBC Capital Maintains Sector Perform on Sarepta Therapeutics, Raises Price Target to $18 (opens in a new tab) Benzinga · 06 Nov 2026 15:00
- SRPT Q3 Earnings Miss Estimates, Stock Down as Elevidys Sales Decline (opens in a new tab) Zacks · 06 Nov 2026 14:21
- Sarepta Therapeutics Inc (SRPT) Q3 2026 Earnings Call Highlights: Revenue Guidance Raised ... (opens in a new tab) GuruFocus.com · 06 Nov 2026 11:18
- Sarepta Therapeutics Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 06 Nov 2026 09:14
- Sarepta Therapeutics (NASDAQ:SRPT) Q3 2026 Beat Fails to Lift Shares as Pipeline Readouts Loom (opens in a new tab) ChartMill · 06 Nov 2026 00:48
- Sarepta Therapeutics (SRPT) Q3 Earnings Lag Estimates (opens in a new tab) Zacks · 06 Nov 2026 00:00
- Compared to Estimates, Sarepta Therapeutics (SRPT) Q3 Earnings: A Look at Key Metrics (opens in a new tab) Zacks · 05 Nov 2026 23:30
- Sarepta Therapeutics: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 05 Nov 2026 22:09
- Sarepta Therapeutics Announces Third Quarter 2026 Financial Results and Recent Corporate Developments (opens in a new tab) 05 Nov 2026 21:05
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 16.01 USD
- Market cap
- 1.7B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow SRPT and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.